Skip to content

Clinical trials

Phase 3 Amyotrophic Lateral Sclerosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyotrophic Lateral Sclerosis Phase: Phase 3 Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20061
20071
20092
20111
20121
20131
20151
20162
20171
20182
20192
20202
20214
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated8
Active, not recruiting2
Recruiting2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cytokinetics4
Avanir Pharmaceuticals2
Brainstorm-Cell Therapeutics2
Knopp Biosciences2
Orion Corporation, Orion Pharma2
ZevraDenmark2
AB Science1
Alector Inc.1
Alexion Pharmaceuticals, Inc.1
Amylyx Pharmaceuticals Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyotrophic Lateral Sclerosis29
Motor Neuron Disease4
Multiple Sclerosis2
Frontotemporal Dementia1
Major Depressive Disorder1
Neurodegenerative Diseases1
Parkinson Disease1
Sialorrhea1
Stroke1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.